|
Clinical Trial Regulations of Personalized Medicine
|
|
| Author:
|
TEENA SHERIN M, ARUN RADHAKRISHNAN
|
| Abstract:
|
Personalized medicine is a clinical model that isolates individuals into various groups with clinical choices, practices, intercessions and additionally items being customized to the individual patient dependent on their anticipated reaction or danger of disease. The utilization of genetic data has assumed a significant part in personalized medicine (e g pharmacogenomics). Modern advances in personalized medicine depend on innovation that affirms a patient's major DNA, RNA, biology or protein, which at last prompts confirming disease. The ideas of personalized medication can be applied to new and extraordinary ways to deal with medical services. The history of personalized medicine is clearly discussed in this article. And with that, literature review on various type of clinical trial was done. The two types of clinical trials are conventional clinical trial and differential clinical trial. The conventional clinical trial is a regular trial in which simple drugs are evaluated and the study can be done by observing all the phases. But in the case of differential clinical trial, the clinical trial is been carried out on complicated diseases and personalized medicines, where there are no proper regulatory guidelines to be followed. It is concluded that the advancing field of personalized medication is an emerging zone with a range of applications for rare diseases, which include actual advances in clinical trial outcomes for properly chosen patient sub-sets.
|
| Keyword:
|
personalized medicine, conventional clinical trials, differential clinical trials.
|
| EOI:
|
-
|
| DOI:
|
https://doi.org/10.31838/ijpr/2021.13.01.601
|
| Download:
|
Request For Article
|
|
|